Peeing shouldn't be painful-yet all too often it is. If you've found yourself wondering "Why does it burn when I pee?", ...

Data from the phase 3 ENVISION trial demonstrate the potential of UGN-102 as an effective and durable nonsurgical treatment ...

Ferring Pharmaceuticals announced today three abstracts featuring ADSTILADRIN® (nadofaragene firadenovec-vncg) will be presented at the 2025 American Society of Clinical Oncologists Genitourinary ...

The symptoms of vulvovaginal atrophy, such as vaginal dryness, irritation, itching, dysuria and dyspareunia ... Local estrogen therapy is the treatment of choice for women with vulvovaginal ...

Porizkova, 59, says women "don’t need a steady partner, just a desire to explore" their sexuality as they age.

The risk factors for treatment non-adherence include dosing ... exacerbation of psychosis and dysuria. The use of concomitant anticholinergics decreased from 15.0% to 8.3%. Conclusions The results ...

In addition, adulterants in drugs can cause rashes at injection sites ... He reported no diarrhea, dysuria, abdominal pain, nausea, vomiting, or vision changes. Although his use of emtricitabine ...

Financially, UroGen has a market cap of $464mn and a cash runway of 8-9 quarters, despite facing patent challenges from Teva. Despite promising data and market potential, UroGen's low market cap ...

The patient reported no chest pain, dyspnea, orthopnea, paroxysmal nocturnal dyspnea, abdominal pain, diarrhea, vomiting, dysuria ... and anxiety. Medications included aspirin, ticagrelor ...

Walmart sells millions of dollars worth of groceries a year. Sometimes, things go wrong. These are the biggest food recalls ...